Showing results (1-10 of 75) with videos related to
Sort By:
Pageof 8
Expert Review of Vaccines|March 24, 2015
Biosynthetically engineered lipopolysaccharide as vaccine adjuvantAfshin Zariri, Peter van der LeyMicrolife|May 24, 2023
Lipid A heterogeneity and its role in the host interactions with pathogenic and commensal bacteriaSukumar Saha, Elder Pupo, Afshin Zariri, et al.Scientific Reports|November 15, 2016
Modulating endotoxin activity by combinatorial bioengineering of meningococcal lipopolysaccharideAfshin Zariri, Elder Pupo, Elly van Riet, et al.Vaccines|October 14, 2020
Shortening the Lipid A Acyl Chains of Bordetella pertussis Enables Depletion of Lipopolysaccharide Endotoxic ActivityJesús Arenas, Elder Pupo, Coen Phielix, et al.The Journal of Infection|June 17, 2014
Meningitis caused by a lipopolysaccharide deficient Neisseria meningitidisJurgen R Piet, Afshin Zariri, Floris Fransen, et al.Infection and Immunity|August 3, 2016
Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune ResponseAfshin Zariri, Joep Beskers, Bas van de Waterbeemd, et al.Journal of Endotoxin Research|June 14, 2003
Lessons from an LPS-deficient Neisseria meningitidis mutantPeter van der Ley, Liana SteeghsVaccine|August 13, 2013
Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesiclesAfshin Zariri, Harry van Dijken, Hendrik-Jan Hamstra, et al.Current Opinion in Immunology|August 20, 2023
Outer membrane vesicle-based intranasal vaccinesPeter Van der Ley, Virgil Ejc SchijnsHuman Vaccines|July 26, 2011
Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutantsPeter van der Ley, Germie van den DobbelsteenPageof 8